DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Sherry N, Hagopian W, Ludvigsson J. et al.
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.
Lancet 2011;
378: 487-497
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.